Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication
Biomolecules · 17.11.2023 · 13 (11) · 1660
DOI: 10.3390/biom13111660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 17.11.2023. Verfasst von Ekaterina Knizhnik und 11 weiteren Autor:innen. Beteiligte Einrichtung: Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia. Hauptthemen laut MEDLINE: Frameshifting, Ribosomal, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, the President of the Russian Federation.
Abstract (Originalsprache)
Ribosomal frameshifting (RFS) at the slippery site of SARS-CoV-2 RNA is essential for the biosynthesis of the viral replication machinery. It requires the formation of a pseudoknot (PK) structure near the slippery site and can be inhibited by PK-disrupting oligonucleotide-based antivirals. We obtained and compared three types of such antiviral candidates, namely locked nucleic acids (LNA), LNA–DNA gapmers, and G-clamp-containing phosphorothioates (CPSs) complementary to PK stems. Using optical and electrophoretic methods, we showed that stem 2-targeting oligonucleotide analogs induced PK unfolding at nanomolar concentrations, and this effect was particularly pronounced in the case of LNA. For the leading PK-unfolding LNA and CPS oligonucleotide analogs, we also demonstrated dose-dependent RSF inhibition in dual luciferase assays (DLAs). Finally, we showed that the leading oligonucleotide analogs reduced SARS-CoV-2 replication at subtoxic concentrations in the nanomolar range in two human cell lines. Our findings highlight the promise of PK targeting, illustrate the advantages and limitations of various types of DNA modifications and may promote the future development of oligonucleotide-based antivirals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435 Moscow, Russia.
- Department of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
- Research and Educational Resource Center for Cellular Technologies of The Peoples' Friendship University of Russia, 117198 Moscow, Russia.
- Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia.
- Raman Spectroscopy Laboratory, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.
ORCID-Profile: Ekaterina Knizhnik, Stepan Chumakov, Iulia Pavlova, Yuri Khodarovich, Vladimir Brylev, Vjacheslav Severov, Andrey Aralov
Förderung
- Russian Science Foundation
- the President of the Russian Federation
Zitieren
APA
Knizhnik, E., Chumakov, S., Svetlova, J., Pavlova, I., Khodarovich, Y., Brylev, V., Severov, V., Alieva, R., Kozlovskaya, L., Andreev, D., Aralov, A., & Varizhuk, A. (2023). Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication. Biomolecules, 13(11), 1660. https://doi.org/10.3390/biom13111660
Vancouver
Knizhnik E, Chumakov S, Svetlova J, Pavlova I, Khodarovich Y, Brylev V, et al. Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication. Biomolecules. 2023;13(11):1660. doi:10.3390/biom13111660
BibTeX
@article{Knizhnik2023,
author = {Knizhnik, Ekaterina and Chumakov, Stepan and Svetlova, Julia and Pavlova, Iulia and Khodarovich, Yuri and Brylev, Vladimir and Severov, Vjacheslav and Alieva, Rugiya and Kozlovskaya, Liubov and Andreev, Dmitry and Aralov, Andrey and Varizhuk, Anna},
title = {Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {11},
pages = {1660},
doi = {10.3390/biom13111660}
}
EUVIMED